A LOTT of Oxygen: An Update

When:  Jun 6, 2017 from 13:00 to 14:00 (CT)
Associated with  Pulmonary Disease Management

Long-term oxygen therapy has been proven to improve survival in COPD patients with severely impaired oxygenation. However, does the COPD patient with moderately impaired oxygenation also benefit from supplemental long-term oxygen therapy? The Long-Term Oxygen Treatment Trial (LOTT), a randomized clinical trial published in 2016, was designed to evaluate the efficacy of supplemental oxygen for this patient population. This presentation will discuss the design and results of the multi-center LOTT and the implications on patient care.

This Live AARC webcast is approved for 1.0 CRCE

Speaker: Jerry Krishnan MD, PhD

This webcast is sponsored by an unrestricted educational grant from ResMed Inc.

ResMed-Logo.jpg

Location

Dial-in Instructions: